Маркова, М.; Христов, Г. Reporting of R&D Costs Under IAS 38 – The Case of Biopharmaceutical Companies. НТ 2023, бр. 4, 57-65. https://doi.org/https://doi.org/10.37075/RP.2022.4.04.